Showing results (131-140 of 304) with videos related to
Sort By:
Pageof 31
JHEP Reports : Innovation in Hepatology|March 26, 2026
Advanced: post-hoc analysis of the ABC-01, -02 and -03 clinical trialsAngela Lamarca, Paul Ross, Harpreet S Wasan, et al.Journal of Gastrointestinal Cancer|March 2, 2011
Expression profile as predictor of relapse after adjuvant treatment in gastric cancerMaría Sereno, Javier De Castro, Paloma Cejas, et al.Future Oncology (London, England)|January 12, 2024
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumorsChanghoon Yoo, Angela Lamarca, Hye Jin Choi, et al.Neuroendocrinology|October 29, 2019
High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine TumorsJohan Botling, Angela Lamarca, Duska Bajic, et al.Journal of the National Cancer Institute|May 12, 2019
Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical TrialsAngela Lamarca, Paul Ross, Harpreet S Wasan, et al.Cancers|July 26, 2020
Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)Vera G Megdanova-Chipeva, Angela Lamarca, Alison Backen, et al.Oncotarget|February 22, 2018
The transcriptional and mutational landscapes of lipid metabolism-related genes in colon cancerLara P Fernández, Ricardo Ramos-Ruiz, Jesús Herranz, et al.Molecular Oncology|October 6, 2017
MicroRNA-661 modulates redox and metabolic homeostasis in colon cancerMarta Gómez de Cedrón, Rebeca Acín Pérez, Ruth Sánchez-Martínez, et al.Cancer Treatment Reviews|July 12, 2021
Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysisJulien Edeline, Angela Lamarca, Mairéad G McNamara, et al.Cancer Treatment Reviews|November 5, 2023
Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinomaAngela Lamarca, Lorena Ostios, Mairéad G McNamara, et al.Pageof 31